Informa
BioProcess International
2025年9月15-18日
美國, 麻薩諸塞州波士頓, Hynes Convention

演讲嘉宾

BioProcess International 吸引了生物加工领域最聪明的人才，为您提供加速生物制剂走向商业成功所需的尖端科学。我们 2025 年的演讲嘉宾代表了全球 20 家最大制药公司中的 16 家，此外还有 70 多家独特的中小型制药公司和生物技术公司，他们分享了最新案例研究和新的数据演示，以帮助您提高生物加工各个阶段的效率。

Niklas Engler

Global Head and Vice President, Technical Development Portfolio and Projects

F. Hoffmann-La Roche

Thomas Seewoester

Vice President External Supply

Amgen

James Warren

VP Pharmceutical Development

Ultragenyx

Nick Aldens

Associate Director, Analytical Development Automation

Ultragenyx Pharmaceutical

Andrei Arion

Associate Scientist, Cell Line and Upstream Process Development

Alexion, AstraZeneca Rare Disease

Jordan Ball

Sr. Manager, Technology Transfer

Regeneron

James Blackwell

President and Principal Consultant

The Windshire Group, LLC

Mark Blenner

Associate Professor

University of Delaware

Mr Rajeev Boregowda

Associate Director, Bioassay & Molecular Analytical Development, Genomic Medicine CMC

Sanofi

Mahesh Bule

Associate Director

Kite Pharma a Gilead Company

Daniel Burke

Senior Scientist

Merck

Ying Cai

MSAT Executive Director

Ultragenyx Pharmaceutical

Brenda Carillo-Conde

Group Leader

Pfizer

Wolfram Carius, PhD

Executive Vice President, Pharmaceuticals, Cell and Gene Therapy

Bayer Pharmaceuticals

Lina Chakrabarti

Associate Director, R & D

Astrazeneca

Callum Chapman

Senior Director,  Product Quality

Product Quality

Jeron Chen

Head of Data Science and Payload Innovation

Voyager Therapeutics

Wei-Chiang Chen

Associate Director, BioProcess Analytics, Genomic Medicine Unit

Sanofi

Mark Farmery

Chief Development Officer

Anocca AB

Aaron Fisher

Director, Life Sciences Investments

ARCHIMED

Daniel Friedman

Principal

BroadOak Capital

Jack Greene

Chief Technical and Manufacturing Officer

JucaBio

Reagan Jarvis

Chief Executive Officer and Co-founder

Anocca

Stephen Kennedy

Head of Technical Operations

CRISPR Therapeutics

Erin Kimbrel

President & Head

Astellas Institute for Regenerative Medicine

Parag Kumthekar

Gene Therapy Downstream Process Development Lead

UCB Pharma

Marcus Lehmann

Associate Director, Drug Product Process Development

Satellite Bio

Seth Levy

Senior Director, Bioprocess Development

Modalis Therapeutics

Jun Li

Associate Director – Upstream Process Development: Gene Therapy

Ultragenyx Pharmaceutical

Ana Di Lillo

Scientist

AstraZeneca

Yuxin Liu

Scientist, Cell Culture Platform

Sanofi

Jarrod Longcor

Chief Operating Officer

Cellectar Biosciences

Junfen Ma

Head of Genomic Medicine Purification Process Development

Sanofi

Victor Manuel Diaz Cortes

Research Director

OneChain Immunotherapeutics S.L.

Lynn Mao

Senior Scientist

AstraZeneca

Jeff Masten

Senior Vice President CMC

Secretome Therapeutics

Bhanu Chandra Mulukutla

Group Leader

Pfizer

Shashi Murthy, PhD

CTO and Co-Founder

Nanite Inc.

Prasad Pathange

Senior Manager

Bayer U.S.

Tracy Payne

SVP Business Development, Principal Consultant Business Strategy & Operations

Windshire Group, LLC.  Labshire, LLC

Lorena Pena

Scientist

Bristol-Myers Squibb

Lorraine Peters

Associate Principal Scientist

AstraZeneca

Christine Pham

Principal Scientist, Purification Process Development

Gilead

Bryan Poltilove

Strategic Advisor and Independent Board Director

Independent

Shashi Prajapati

Director, Cell & Gene Therapies Analytical Development

Vertex Pharmaceuticals

Matthew Provencal

Executive Director Gene Therapy BDS Manufacturing

Sarepta

Monica Raimo

Director, Product and Process Development

Glycostem Therapeutics

Mr Phillip Ramsey

Senior Vice President, Technical Operations

Sangamo Therapeutics

Hunter Reese

Scientist II

Asklepios Biopharmaceutical

Kate Rochlin

Chief Operating Officer

IN8bio

Shruti Santhosh

Engineer II

Biogen

Dana Schreffler

Sr. Manager QC Viral Safety

Regeneron

Jacqualyn Schulman, Ph.D.

Scientist, Cell Line Development & ・ｽeOmics Biologics Development

Bristol-Myers Squibb

Susan Sharfstein, PhD

Professor of Nanobioscience, College of Nanoscale Science and Engineering

SUNY Polytechnic Institute

Amy Shaw

Head of Process and Product Development

Takeda, USA

Edwin Shen

Principal Scientist

Pfizer

Michael Si

Scientist

Sanofi

Wonjong Si

Associate Director, Cell Therapy Platform Process

Bayer

Justin Skoble

Vice President of Technical Development

Caribou Biosciences, Inc.

Fernanda Sobreira

Associate Principal Scientist

Merck

Zhiwei Song

Senior Principal Scientist

A*STAR

Dr. Anand Srinivasan

Vice President of Technology and Innovations, and Head of the Center for Innovations and Biodesign

BioBridge Global

Arvind Srivastava, Ph.D.

Senior Vice President

ThirdArcBio

Xiaodong Sun

Senior Scientist

Takeda

Shankar Swaminathan, PhD

Team Lead, Associate Director Drug Product Development

Astellas Institute for Regenerative Medicine

Ms Mariska ter Haak

Senior Director Analytical Development

IN8bio

Crystal Thomas

Process Engineer III

Sanofi

Sarah Thomas

Senior Vice President, Quality

REGENXBIO Inc.

Shawn (Xueyuan) Wang

Director, Process Development

Kite Pharma

Shu Wang

Principal Investigator

Incyte

Kristy Wood, PhD

SVP, Technical Operations

Intellia Therapeutics

Jianlin (Jim) Xu Xu

Global Head of Cell Culture Platform

Sanofi

Yifeng Xu

Principal Scientist

Pfizer

Dong Xu, Ph.D.

Associate Director, Cell Therapy Analytical Development

TScan Therapeutics

Ms Huize Yan

Process Development Scientist

Spark Therapeutics

Lena Yang

Senior Scientist, Cell Therapy Analytical Development

Takeda

Shu Yang

Senior Scientist

Pfizer

Gregory Zarbis-Papastoitsis, Ph.D

Chief Process and Manufacturing Officer

Ankyra

Hao Zhang

Sr. Principal Scientist

Amgen

Kate Zhao

Scientist I, Upstream Process Development

Alexion, AstraZeneca Rare Disease

Yuechen Zhu

Staff Development Scientist

Bayer

Filter
Streams